retatrutide clinical trial results shows 30% weight loss in | Darshan Shah posted on the topic BEYOND OZEMPIC: ELI LILLY RETATRUTIDE
Description
Diabetes, Obesity & Metabolism, 23(2), 581588
If you started 10 weeks ago on Wegovy, you should be at 1.0 mg (weeks 912)
doi: 10.1210/EN.2014-1675
[19] All adverse events including musculoskeletal complaints must be recorded and assessed for potential relatedness to the investigational product by the trial team
Across GLP-1 medications, the same three injection sites are recommended: your abdomen, the front or outer part of your thigh, and the back of your upper arm
